JXR executes additional HKD 7.81 million share buyback; cumulative repurchases hit 65.87 million shares under 2025 mandate

Bulletin Express05-13

Jinxin Fertility Group Limited (abbreviation: JXR) disclosed a new round of on-market share repurchases on 13 May 2026.

Key points

• Latest transaction: 3.27 million ordinary shares were bought back on the Hong Kong Stock Exchange at prices between HKD 2.38 and HKD 2.43, for a total consideration of HKD 7.81 million. All shares are designated for cancellation.

• Outstanding shares: Issued share capital stood unchanged at 2.71 billion shares as of 13 May 2026, as the repurchased shares await formal cancellation.

• Pending cancellation pool: Including the 13 May purchase, JXR has 26.21 million shares bought back but not yet cancelled since 27 March 2026, equivalent to approximately 0.97% of current issued shares.

• Mandate utilisation: Since the AGM approval on 26 June 2025, the company has repurchased 65.87 million shares—about 2.40% of the shares outstanding on the mandate date—under its authorised limit of 274.47 million shares.

• Moratorium: In accordance with Hong Kong listing rules, JXR is restricted from issuing new shares or transferring treasury shares until 12 June 2026, 30 days after the most recent buyback.

These transactions are confirmed to comply with the Hong Kong Stock Exchange’s Main Board Rules, and no material changes have been made to the company’s previously filed explanatory statement dated 4 June 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment